Back to Browse Journals » International Journal of Nanomedicine » Volume 7

Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body

Authors Jiang Z, Wang T, Pan B, Xie Z, Wang P, Liu Y, Gao Q

Published Date December 2011 Volume 2012:7 Pages 1—10

DOI http://dx.doi.org/10.2147/IJN.S25268

Published 30 December 2011

Zhaoxin Jiang1, Ting Wang1, Biyan Pan2, Zhiyong Xie2, Peijuan Wang1, Yaqin Liu1, Qianying Gao1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, People's Republic of China; 2Laboratory of Pharmaceutical Analysis and Quality Assessment, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, People's Republic of China

Abstract: The authors have manufactured a novel rabbit foldable capsular vitreous body (FCVB). The aim of this study was to determine whether this rabbit FCVB can release levofloxacin in vitro and in vivo, and to evaluate the release characteristics. In vitro, the rabbit FCVB with levofloxacin 500 µg/mL was immersed in cups of modified Franz diffusion cells. Following this, 200 µL of liquid was aspirated at intervals from 10 minutes to 24 hours. In vivo, the FCVB with levofloxacin was implanted into the right eyes of five rabbits. After implantation, the aqueous humor was aspirated on days 1, 7, 14, 28, and 56. The levofloxacin concentrations in the cups and aqueous humor samples were detected by high-performance liquid chromatography–tandem mass spectrometry. The FCVB was observed under a scanning electron microscope. The results showed that the released levofloxacin was stabilized at 20 ng/mL at time points from 10 minutes to 24 hours in vitro. In vivo, levofloxacin concentrations in the aqueous humor were 132, 50, 39, 11, and 15 ng/mL on days 1, 7, 14, 28, and 56, respectively. In the FCVB capsules, 300 nm apertures were observed. These results suggest the rabbit FCVB released levofloxacin stably in vitro and sustainably in vivo. This study provides a novel combined approach, with the FCVB as a vitreous substitute and drug delivery system for the treatment of bacterial endophthalmitis.

Keywords: drug delivery system, high-performance liquid chromatography–tandem mass spectrometry, vitreous substitute, bacterial endophthalmitis

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Liposomes and nanotechnology in drug development: focus on ocular targets

Honda M, Asai T, Oku N, Araki Y, Tanaka M, Ebihara N

International Journal of Nanomedicine 2013, 8:495-504

Published Date: 14 February 2013

Cytocompatible antifungal acrylic resin containing silver nanoparticles for dentures

Acosta-Torres LS, Mendieta I, Nuñez-Anita RE, Cajero-Juárez M, Castaño VM

International Journal of Nanomedicine 2012, 7:4777-4786

Published Date: 3 September 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Lysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studies

Kaur R, Chitanda JM, Michel D, Maley J, Borondics F, Yang P, Verrall RE, Badea I

International Journal of Nanomedicine 2012, 7:3851-3866

Published Date: 19 July 2012

Brain-targeting study of stearic acid–grafted chitosan micelle drug-delivery system

Xie YT, Du YZ, Yuan H, Hu FQ

International Journal of Nanomedicine 2012, 7:3235-3244

Published Date: 29 June 2012

Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo

Wu Y, Sadatmousavi P, Wang R, Lu S, Yuan YF, Chen P

International Journal of Nanomedicine 2012, 7:3221-3233

Published Date: 28 June 2012

Catalytically active bovine serum amine oxidase bound to fluorescent and magnetically drivable nanoparticles

Sinigaglia G, Magro M, Miotto G, Cardillo S, Agostinelli E, Zboril R, Bidollari E, Vianello F

International Journal of Nanomedicine 2012, 7:2249-2259

Published Date: 3 May 2012

Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction

Carreño E, Portero A, Galarreta DJ, Herreras JM

Clinical Ophthalmology 2012, 6:637-644

Published Date: 27 April 2012